Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Revenue

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹10,728 Cr₹9,620 Cr₹8,508 Cr₹8,005 Cr₹7,939 Cr

What is the latest Revenue of TORRENT PHARMACEUTICALS ?

The latest Revenue ratio of TORRENT PHARMACEUTICALS is ₹10,728 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹10,728 Cr
Mar2024₹9,620 Cr
Mar2023₹8,508 Cr
Mar2022₹8,005 Cr
Mar2021₹7,939 Cr

How is Revenue of TORRENT PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹10,728 Cr
11.51
Mar2024 ₹9,620 Cr
13.07
Mar2023 ₹8,508 Cr
6.29
Mar2022 ₹8,005 Cr
0.82
Mar2021 ₹7,939 Cr -

Compare Revenue of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹129,284.0 Cr 0% 2.7% 11% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,590.0 Cr -2% -6.1% -6.7% Stock Analytics
DIVIS LABORATORIES ₹170,577.0 Cr -0.8% -0.8% 8.7% Stock Analytics
CIPLA ₹120,471.0 Cr -0.6% -2.6% 0.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,660.0 Cr -1.3% 0.6% -6.4% Stock Analytics
MANKIND PHARMA ₹88,885.2 Cr -3.5% -4.4% -25.1% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

0%

2.7%

11%

SENSEX

-1%

-1.2%

7.9%


You may also like the below Video Courses